Surgical and interventional therapies for pulmonary arterial hypertension

被引:14
|
作者
Olsson, JK
Zamanian, RT
Feinstein, JA
Doyle, RL
机构
[1] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA USA
[3] Stanford Univ, Sch Med, Vera M Wall Ctr Pulm Vasc Dis, Stanford, CA USA
关键词
pulmonary arterial hypertension; congenital heart disease; pulmonary thromboendarterectomy; lung and heart-lung transplantation; atrial septostomy;
D O I
10.1055/s-2005-916157
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Surgical and interventional therapies for pulmonary arterial hypertension (PAH) in appropriately selected patients have the potential to dramatically improve or, in some cases, cure PAH. These include atrial septostomy, a palliative procedure or bridge to transplantation in patients with refractory right heart failure, pulmonary thromboendarterectomy for pulmonary hypertension associated with chronic thromboembolic disease, and closure of congenital systemic-pulmonary shunts in patients with PAH but without significant pulmonary vascular disease. Lung transplantation should be considered for patients with all forms of PAH who demonstrate advanced or progressive disease.
引用
收藏
页码:417 / 428
页数:12
相关论文
共 50 条
  • [31] Pediatric Pulmonary Arterial Hypertension
    Wu, Dan-Chen
    Zhang, Hong-Da
    Jing, Zhi-Cheng
    CURRENT HYPERTENSION REPORTS, 2013, 15 (06) : 606 - 613
  • [32] Epidemiology of Pulmonary Arterial Hypertension
    Jiang, Xin
    Jing, Zhi-Cheng
    CURRENT HYPERTENSION REPORTS, 2013, 15 (06) : 638 - 649
  • [33] Pediatric Pulmonary Arterial Hypertension
    Dan-Chen Wu
    Hong-Da Zhang
    Zhi-Cheng Jing
    Current Hypertension Reports, 2013, 15 : 606 - 613
  • [34] Pulmonary hypertension and right ventricular failure. Part XIII. Surgical methods of treatment of various forms of pulmonary arterial hypertension
    Batyraliev, T. A.
    Ekinci, E.
    Pataraya, S. A.
    Pershilikov, In.
    Sidorenko, B. A.
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2007, 47 (12) : 67 - 73
  • [35] Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
    Savale, Laurent
    Manes, Alessandra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0K) : 37 - 45
  • [36] Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?
    Alison M. MacKenzie
    Andrew J. Peacock
    Current Hypertension Reports, 2015, 17
  • [37] Oxidative and nitrosative signalling in pulmonary arterial hypertension Implications for development of novel therapies
    Hansen, Thomas
    Galougahi, Keyvan-Karimi
    Celermajer, David
    Rasko, Nathalie
    Tang, Owen
    Bubb, Kristen J.
    Figtree, Gemma
    PHARMACOLOGY & THERAPEUTICS, 2016, 165 : 50 - 62
  • [38] Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?
    MacKenzie, Alison M.
    Peacock, Andrew J.
    CURRENT HYPERTENSION REPORTS, 2015, 17 (07)
  • [39] Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical Therapies
    van Loon, Rosa Laura E.
    Roofthooft, Marcus T. R.
    Delhaas, Tammo
    van Osch-Gevers, Magdalena
    ten Harkel, Arend D. J.
    Strengers, Jan L. M.
    Backx, Ad
    Hillege, Hans L.
    Berger, Rolf M. F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (01): : 117 - 124
  • [40] Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
    Khan, Sarah L.
    Mathai, Stephen C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 380 - 390